Education
About Us
Working with TipRanks
Follow Us
Labcorp Holdings (LH)
NYSE:LH
LH Analyst Ratings
Strong Buy
11 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LH Stock 12 Month Forecast
Average Price Target
$278.38
▲(20.16% Upside)
| Highest Price Target$300.00 | Average Price Target$278.38 | Lowest Price Target$248.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Mizuho Securities
Reiterated
03/13/25
Truist Financial
Reiterated
03/11/25
Argus Research
Reiterated
03/06/25
J.P. Morgan
Reiterated
02/12/25
Leerink Partners
Reiterated
02/10/25
Piper Sandler
Reiterated
02/10/25
Robert W. Baird
Reiterated
02/07/25
Deutsche Bank
Reiterated
02/07/25
Evercore ISI
Reiterated
02/07/25
Barclays
$271→$260
Hold
12.23%
Upside
Reiterated
02/07/25
Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (NYSE: LH), Encompass Health (NYSE: EHC) and Globus Medical (NYSE: GMED)
Jefferies
$275→$290
Buy
25.18%
Upside
Reiterated
02/06/25
Labcorp price target raised to $290 from $275 at JefferiesLabcorp price target raised to $290 from $275 at Jefferies
Bank of America Securities
$271→$282
Buy
21.72%
Upside
Reiterated
02/06/25
Labcorp Holdings: Strong Performance, Growth Potential, and Strategic Acquisitions Justify Buy Rating
UBS
$293→$286
Buy
23.45%
Upside
Reiterated
01/28/25
Laboratory Corporation of America (LH) PT Lowered to $286 at UBSUBS analyst Kevin Caliendo lowered the price target on Laboratory Corporation of America (NYSE: LH) to $286.00 (from $293.00) while maintaining a Buy rating.
Morgan Stanley
$260→$270
Buy
16.55%
Upside
Reiterated
12/17/24
Laboratory (LH) Gets a Buy from Morgan Stanley
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Mizuho Securities
Reiterated
03/13/25
Truist Financial
Reiterated
03/11/25
Argus Research
Reiterated
03/06/25
J.P. Morgan
Reiterated
02/12/25
Leerink Partners
Reiterated
02/10/25
Piper Sandler
Reiterated
02/10/25
Robert W. Baird
Reiterated
02/07/25
Deutsche Bank
Reiterated
02/07/25
Evercore ISI
Reiterated
02/07/25
Barclays
$271→$260
Hold
12.23%
Upside
Reiterated
02/07/25
Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (NYSE: LH), Encompass Health (NYSE: EHC) and Globus Medical (NYSE: GMED)
Jefferies
$275→$290
Buy
25.18%
Upside
Reiterated
02/06/25
Labcorp price target raised to $290 from $275 at JefferiesLabcorp price target raised to $290 from $275 at Jefferies
Bank of America Securities
$271→$282
Buy
21.72%
Upside
Reiterated
02/06/25
Labcorp Holdings: Strong Performance, Growth Potential, and Strategic Acquisitions Justify Buy Rating
UBS
$293→$286
Buy
23.45%
Upside
Reiterated
01/28/25
Laboratory Corporation of America (LH) PT Lowered to $286 at UBSUBS analyst Kevin Caliendo lowered the price target on Laboratory Corporation of America (NYSE: LH) to $286.00 (from $293.00) while maintaining a Buy rating.
Morgan Stanley
$260→$270
Buy
16.55%
Upside
Reiterated
12/17/24
Laboratory (LH) Gets a Buy from Morgan Stanley
LH Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
0
0
0
0
Buy
17
16
9
14
15
Hold
7
7
2
4
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
24
23
11
18
19
Each month's total comprises the sum of three months' worth of ratings.
LH Financial Forecast
LH Stock Forecast FAQ
What is LH’s average 12-month price target, according to analysts?
Based on analyst ratings, Labcorp Holdings’s 12-month average price target is $278.38.
What is LH’s upside potential, based on the analysts’ average price target?
Labcorp Holdings has 20.16% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LH a Buy, Sell or Hold?
Labcorp Holdings has a consensus rating of Strong Buy which is based on 11 buy ratings, 3 hold ratings and 0 sell ratings.
What is Labcorp Holdings’s price target?
The average price target for Labcorp Holdings is $278.38. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $300.00 ,the lowest forecast is $248.00. The average price target represents 20.16% Increase from the current price of $231.67.
The highest analyst price target is $300.00 ,the lowest forecast is $248.00. The average price target represents 20.16% Increase from the current price of $231.67.
What do analysts say about Labcorp Holdings?
Labcorp Holdings’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of LH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.